Eli Lilly announces $6.5 billion six-part note offering
Eli Lilly (NYSE:LLY) has filed for a six-part note offering, with the aggregate principal amount of the notes offered ...
GlobalCapital5h
Eli Lilly leads M&A bond charge in US IG market
Corporate borrowers shrugged off fears over inflation and concerns over tariffs to print tight trades and pay for ...
Eli Lilly beats on earnings even as weight loss, diabetes drug sales fall short
Eli Lilly reported mixed results for the fourth quarter, even as demand for its blockbuster weight loss drug Zepbound and ...
Diabetes and obesity drugs fuel Eli Lilly profit in the final quarter of 2024
Eli Lilly’s profit doubled in the fourth quarter, propelled by its hot-selling diabetes and obesity treatments, and the ...
Eli Lilly Stock Rises After Profit, Outlook Top Expectations
Eli Lilly stock is higher Thursday after the pharma giant beat fourth-quarter profit expectations and issued strong 2025 ...
NBC New York7d
Eli Lilly beats on earnings even as weight loss, diabetes drug sales fall short
Analysts had expected the drug to book $3.62 billion in sales for the quarter, according to StreetAccount. Eli Lilly said the increase reflects strong demand and increased supply of Mounjaro ...